Treatment of Congenital Factor VII Deficiency

Conditions

• Congenital Bleeding Disorder
• Congenital FVII Deficiency

Interventions

• DRUG: activated recombinant human factor VII
• DRUG: Fresh frozen plasma (Source unspecified)
• DRUG: Plasma-derived FVII (LFB)
• DRUG: Prothrombin Complex conc. (PCC)
• DRUG: Plasma-derived FVII conc. (pdFVII Baxter)
• DRUG: Plasma-derived FVII conc. (pdFVII PFL)

Sponsor

Novo Nordisk A/S